NCT00205647View on ClinicalTrials.gov

Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

PHASE2CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

January 31, 1997

Study Completion Date

March 31, 2000

Conditions

Chronic Bronchitis

Interventions

DRUG

Oral N-acetycystein (NAC)

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors

collaborator

Zambon SpA

INDUSTRY

lead

Wake Forest University

OTHER

NCT00205647 - Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis | Biotech Hunter | Biotech Hunter